Physician profile
Lin Y Chen
NPI 1205800240
$772.53
in general payments reported to CMS, 2019-2025
10 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $46.05 · 2022: $173 · 2023: $34.38 · 2024: $24.13 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $237.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $193.86 | 2020-2025 | Carto 3 |
| Cvrx, INC. | $173.12 | 2022 | |
| Medtronic Vascular, INC. | $143.75 | 2019 | |
| Biotronik INC. | $103.68 | 2019 | |
| Abbott Laboratories | $69.19 | 2019-2020 | |
| Grifols USA, LLC | $34.38 | 2023 | |
| Boston Scientific Corporation | $24.13 | 2024 | Watchman Flx |
| Atricure, INC. | $17.42 | 2019 | |
| Vifor Pharma, INC. | $13.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lin Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.